Otimizando o componente farmacológico da terapia integrada da vertigem

Drug treatment is an important option for the treatment of peripheral vestibular diseases. AIM: To identify the drug component associated with optimal integrated balance therapy (IBT) for Ménière s disease or other peripheral vestibular disorders. MATERIALS AND METHODS: Analysis of a series of patie...

Descripción completa

Detalles Bibliográficos
Autores: Ganança, Mauricio Malavasi [UNIFESP], Caovilla, Heloisa Helena [UNIFESP], Munhoz, Mário Sérgio Lei [UNIFESP], Ganança, Cristina Freitas [UNIFESP], Silva, Maria Leonor Garcia da [UNIFESP], Serafini, Flavio [UNIFESP], Ganança, Fernando Freitas [UNIFESP]
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2007
País:Brasil
Institución:Universidade Federal de São Paulo (UNIFESP)
Repositorio:Repositório Institucional da UNIFESP
Idioma:portugués
OAI Identifier:oai:repositorio.unifesp.br:11600/3514
Acceso en línea:http://dx.doi.org/10.1590/S0034-72992007000100003
http://repositorio.unifesp.br/handle/11600/3514
Access Level:acceso abierto
Palabra clave:meniere s disease
labyrinth diseases
dizziness
vertigo
doença de ménière
doenças do labirinto
tontura
vertigem
Descripción
Sumario:Drug treatment is an important option for the treatment of peripheral vestibular diseases. AIM: To identify the drug component associated with optimal integrated balance therapy (IBT) for Ménière s disease or other peripheral vestibular disorders. MATERIALS AND METHODS: Analysis of a series of patients with Ménière s disease patients or patients with other peripheral vestibular disorders that received IBT involving either no medication or betahistine, cinnarizine, clonazepam, flunarizine or Ginkgo biloba during 120 days. RESULTS: In Ménière s disease, significant differences were observed for all drug therapies (60 days) versus no medication; betahistine was significantly more effective than all other drugs at 60 and 120 days. For non-Ménière s disorders, significant differences were observed among betahistine, cinnarizine, clonazepam and flunarizine and no medication after 60 days; all drug therapies were significantly more effective than no medication after 120 days; betahistine, cinnarizine or clonazepam were equally effective and betahistine was more effective than flunarizine and EGb 761. All treatment options were well tolerated. CONCLUSIONS: Drug therapies were more effective than no medication in the IBT for patients with Ménière s disease or other peripheral vestibular disorders. Betahistine was the most effective medication for patients with Ménière s disease and was as effective as cinnarizine and clonazepam for other peripheral vestibular disorders.